Epitope-Optimized Influenza Hemagglutinin Nanoparticle Vaccine Provides Broad Cross-Reactive Immunity against H9N2 Influenza Virus

Journal:
ACS Nano
Published:
DOI:
10.1021/acsnano.5c03199
Affiliations:
2
Authors:
7
Go to article
Institutions Authors Share
State Key Laboratory of Virology and Biosafety, China
4.000000
 0.57
University of Chinese Academy of Sciences (UCAS), China
3.000000
 0.43
Interested in Clinical Sciences?